What are CDC recommendations for influenza vaccination?

Updated: Aug 07, 2020
  • Author: Hien H Nguyen, MD, MS; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

The following are influenza vaccine recommendations by the Advisory Committee on Immunization Practices: [8]

  • In the Northern Hemisphere, all persons aged 6 months or older should receive influenza vaccine annually by the end of October, if possible. Influenza vaccination should not be delayed to procure a specific vaccine preparation if an appropriate one is already available.
  • Persons with a history of egg allergy who have experienced only hives after exposure to egg should receive influenza vaccine. Inactivated influenza virus cell culture–based (ccIIV4; Flucelvax) or trivalent or quadrivalent recombinant influenza vaccine (RIV; Flublok) should be used. RIV may be used for persons aged 18 years or older who have no other contraindications. [9]
  • Regardless of allergy history, all vaccines should be administered in settings in which personnel and equipment for rapid recognition and treatment of anaphylaxis are available.
  • A previous severe allergic reaction to influenza vaccine, regardless of the component suspected of being responsible for the reaction, is a contraindication to future receipt of the vaccine.

In addition to vaccination, other public health measures are also effective in limiting influenza transmission in closed environments. Enhanced surveillance with daily temperature taking and prompt reporting with isolation through home medical leave and segregation of smaller subgroups decrease the spread of influenza. [10]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!